Skip to main content
    D

    Daxor Corporation (DXR)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $8.29
    -0.19 (-2.24%)

    Market Cap: $49.51M

    Last updated: Nov 17, 2026 at 10:57 AM ET

    Daxor Corporation (DXR) Financials: Revenue, Profit and Cash Flow

    Updated Jun 30, 2026. Financial statements from company filings, amounts in US dollars.

    Daxor reported revenue of $503.42K for the fiscal year ended Dec 31, 2025, down 76.4% from the year before. That year, net income was $9.17M with a net margin of 1821.5%, operating cash flow was -$604.42K and free cash flow was -$604.42K. The quarter ended Jun 30, 2026 had revenue of $23.02K and net income of -$3.31M.

    Revenue and Margins

    Over the 9 years to Dec 2025, revenue fell from $1.84M, a compound annual decline of 13.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$503.42K-76.4%37.5%1824.7%1821.5%
    Dec 2024$2.13M-93.8%100.0%29.2%25.2%
    Dec 2023$34.59M+448.2%99.5%1.0%0.8%
    Dec 2022$6.31M+8.4%100.0%83.2%82.1%
    Dec 2021$5.82MN/A100.0%81.6%81.6%
    Dec 2020-$996.30KN/AN/AN/AN/A
    Dec 2019-$114.99KN/AN/AN/AN/A
    Dec 2018-$918.45KN/AN/AN/AN/A
    Dec 2017-$1.01M-155.1%N/AN/AN/A
    Dec 2016$1.84MN/A84.9%80.0%79.3%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 1609.8% from the year before. In the quarter ended Jun 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$503.42K$2.13M$34.59M$6.31M$5.82M-$996.30K-$114.99K-$918.45K-$1.01M$1.84M
    Cost of revenue$314.68KN/A$177.07K$1.09M$1.00M$562.83K$488.65K$346.61K$193.97K$276.75K
    Gross profit$188.74K$2.13M$34.41M$6.31M$5.82M-$996.30K-$114.99K-$918.45K-$1.01M$1.56M
    Operating income$9.19M$621.42K$329.74K$5.25M$4.75M-$1.73M-$495.70K-$1.10M-$1.14M$1.47M
    Net income$9.17M$536.33K$280.64K$5.18M$4.75M-$1.71M-$495.70K-$885.77K-$1.24M$1.46M
    EBITDA$9.19M$2.06M$1.12M$5.25M$4.75M-$1.73M-$495.70K-$1.10M-$1.14M$1.47M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Dec 2025Jun 2025Dec 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
    Revenue$23.02K$131.85K$18.35K$695.31K$71.76K$35.88K$82.45K$41.22K$80.97K$40.49K$96.40K$48.20K
    Gross profit-$60.33K-$104.64K$18.35K$620.66K$71.76K$35.88K$82.45K$41.22K$80.97K$40.49K$96.40K$48.20K
    Operating income-$3.31M$9.54M-$269.50K$2.21M-$297.55K-$148.78K$3.06M-$210.79K-$366.46K-$183.23K-$624.21K-$312.10K
    Net income-$3.31M$9.54M-$369.70K$2.17M-$1.63M-$815.41K$3.32M$1.66M-$3.04M-$1.52M$6.99M$3.50M
    Last 12 quarters

    Balance Sheet

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$46.01M$36.63M$34.87M$30.26M$24.98M$16.55M$14.20M$17.63M$19.31M$20.62M
    Current assetsN/A$18.57K$25.88K$37.84K$764.50K$29.30K$32.74K$36.72K$45.27K$2.62M
    Cash and equivalentsN/AN/AN/AN/A$710.70K$617.80KN/AN/A$1.09M$2.18M
    Total liabilities$122.59K$840.30K$858.76K$1.29M$3.83M$877.69K$1.44M$4.56M$5.55M$5.28M
    Short-term debtN/AN/AN/AN/A$715.80K$627.00K$1.34M$4.45M$4.33M$2.80M
    Long-term debtN/AN/AN/AN/AN/AN/A$1.34M$4.45M$4.33M$2.80M
    Shareholder equity$45.89M$35.79M$34.01M$28.97M$21.15M$15.68M$12.77M$13.06M$13.76M$15.34M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Dec 2025Jun 2025Dec 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
    Total assets$51.86M$46.01M$35.90M$36.63M$34.38M$34.38M$34.87M$34.87M$30.36M$30.36M$30.26M$30.26M
    Total liabilities$23.60K$122.59K$272.43K$840.30K$1.72M$1.72M$858.76K$858.76K$0N/A$1.29M$1.29M
    Shareholder equity$51.83M$45.89M$35.63M$35.79M$32.66M$32.66M$34.01M$34.01M$30.36M$30.36M$28.97M$28.97M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$604.42K$25.69K-$3.66M-$769.30K-$2.76M-$2.45M$3.11M-$1.32M-$1.17M$1.59M
    Capital expenditures$0$4$1$4$3$0$0$0$0$0
    Free cash flow-$604.42K$25.69K-$3.66M-$769.30K-$2.76M-$2.45M$3.11M-$1.32M-$1.17M$1.59M
    Dividends paidN/AN/AN/AN/AN/AN/AN/AN/A$112.10K$113.99K
    Investing cash flow$1.18M$1.94M$2.75M$2.69M$74.76K$367.93K$5.19MN/AN/AN/A
    Financing cash flow-$570.94K-$25.69K$3.66M$58.60K$2.85M$3.07M-$3.11M$226.39K$1.17M-$1.59M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Dec 2025Jun 2025Dec 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Operating cash flow-$2.51M-$297.47K$467.04K-$502.05K-$1.41M-$446.99K-$3.79M-$391.56K-$2.61M-$1.44M-$1.85M
    Capital expenditures$0$4$4$3$3$0$0$0$0$0$0
    Free cash flow-$2.51M-$297.47K$467.04K-$502.05K-$1.41M-$446.99K-$3.79M-$391.56K-$2.61M-$1.44M-$1.85M
    Last 11 quarters

    Frequently Asked Questions About DXR

    What is Daxor's annual revenue?

    Daxor reported revenue of $503.42K for the fiscal year ended Dec 31, 2025.

    How fast is Daxor's revenue growing?

    Revenue was down 76.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -57.0%.

    Is Daxor profitable?

    Yes. Daxor reported net income of $9.17M for the fiscal year ended Dec 31, 2025, with a net margin of 1821.5%.

    How much free cash flow does DXR generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$604.42K minus capital expenditures of $0 produced free cash flow of -$604.42K.

    What is DXR's profit margin?

    For the fiscal year ended Dec 31, 2025, Daxor reported gross margin of 37.5%, operating margin of 1824.7% and net margin of 1821.5%.